Medical University of Vienna

Medical University of Vienna

Medical University of Vienna   link
Spitalgasse 23, 1090 Wien
Währinger Gürtel 18-20, 1090 Wien

Category: Health

news.myScience

Roland Beisteiner takes up professorship in the field of Neurology

Health - Life Sciences

Roland Beisteiner, a specialist in neurology and psychiatry at the Department of Neurology, took up a professorship (§99/1) in the field of Neurology at MedUni Vienna at the beginning of April. Roland Beisteiner conducts research in the field of non-invasive fuctional brain diagnostics and functional brain therapy.

New insights on polymicrobial infections in chronic lung diseases

Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study team led by MedUni Vienna has identified two types of these so-called dysbioses in cystic fibrosis. They display distinct ecology and are also likely to respond differently to treatment. The study was published in the renowned journal Nature Communications.

Inhibition of epigenetic control enzymes in immune cells as a potential new starting point in cancer immunotherapy

Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body's own immune system to fight a tumor.

Heart: New heart valve prosthesis enables broader applicability

A catheter-based tricuspid valve replacement with a newly approved heart valve was performed for the first time in Austria at University Hospital Vienna and MedUni Vienna. The new heart valve prosthesis now also makes it possible to treat patients who could previously only be treated with medication for anatomical reasons or due to the cause of the heart valve leak.

New therapy proven effective against rejection in kidney transplantation

Pharmacology - Health

Antibody-mediated rejection (AMR) is one of the most common causes of kidney transplant failure. To date, however, no treatment has proven effective in combating this complication in the long term.

International VEGANScreener project assesses the nutritional quality of vegans

Health - Agronomy

An international research group led by MedUni Vienna has developed VEGANScreener, a new tool with 29 questions on the dietary quality of vegans in Europe. The tool aims to provide a quick overview of dietary habits and identify potential areas for improvement. This should help vegans and healthcare providers to assess diet quality, set dietary goals and track progress over time.

Long Night of Research: Welcome to the future of medicine!

Health - Life Sciences

MedUni Vienna is once again taking part in the Long Night of Research with numerous attractions.

Health - May 8

Frequent salting of food increases the risk of stomach cancer

In Asian countries, where high-salt foods are popular, the link between high salt consumption and stomach cancer has already been proven. A long-term study by MedUni Vienna has now shown for the first time that this risk is also reflected in the cancer statistics in Europe.

One million people in Austria affected by migraine

Around four billion people worldwide are affected by recurring headaches, and over 356 million spend more days of their lives with than without a "thunderstorm in their head".

Best Abstract Award for Tobias Schiffler and colleagues for ’CoMitMent project’

Tobias Schiffler from MedUni Vienna's Center for Public Health, together with his project colleagues Christopher Tupy and Lisa Kainzbauer, received the Best Abstract Award for their presentation of the CoMitMent project at the Sixth International Psychiatry Congress on Mental Health and Recovery in Bern.

Prostate cancer: Protein identified to reduce tumour growth

As prostate cancer progresses, it becomes increasingly aggressive and can metastasise. In this form, the tumour is difficult to treat, which is reflected in high mortality rates: Worldwide, the malignant disease of the prostate is the second most common cause of cancer death in men.

New findings on the prevention of rejection reactions in organ transplants

Immunosuppressive drugs protect transplanted organs from harmful immune reactions. Nevertheless, rejection reactions can still occur. A MedUni Vienna research team led by Thomas Wekerle has deciphered mechanisms that lead to rejection despite the use of the latest immunosuppressive drugs. These findings point to new therapeutic options for preventing such rejection reactions in the future. The results were recently published in the journal "Nature Communications".

CD Laboratory for Image- and Cognition-based Precision Radiotherapy opened at MedUni Vienna

Health - Laboratory

Image-guided radiotherapy is a central component of modern personalized cancer treatment. To further improve this option, the Christian Doppler Laboratory for Imageand Cognition-based Precision Radiotherapy has been opened at MedUni Vienna. The research facility is headed by Barbara Knäusl and Maximilian Schmid from MedUni Vienna's Department of Radiation Oncology.

Philipp Velicky honored with Scientific Milestone Award of the 2024 Wilhelm Exner Lectures

First author Philipp Velicky, Head of MedUni Vienna's Imaging Core Facilities, has been awarded the "Scientific Milestone Award 2024" by the Wilhelm Exner Medal Foundation for his presentation of an innovative method for imaging brain tissue at this year's Exner Lectures.

Limited efficacy of common local anaesthetic

Liposomal bupivacaine was launched on the market twelve years ago to provide long-lasting local control of pain. The medication is used as a local anaesthetic, particularly for orthopaedic operations. A research study by MedUni Vienna has now shown the limited effectiveness of the substance. The study has just been published in the journal "Anesthesiology", the peer-reviewed journal of the American Society of Anesthesiologists (ASA).

Brain organoid developed for research

The human brain is not only larger and contains more nerve cells than the control center of other species, it is also networked in a very special way: Thick bundles of nerves connect brain regions like highways over long distances, such as the left and right hemispheres of the brain.

Immunotherapy for lung cancer effective even before surgery

Blocking "switches" of the immune system has revolutionized the treatment of patients with various metastatic cancers. In 2018, the discovery of this principle was recognized by the Nobel Prize in Medicine. An international research team has now shown that the simultaneous inhibition of two "immune switches", PD-1 and LAG-3, can lead to the killing of lung cancer cells after just a few weeks. This promising therapeutic approach was recently reported on in the top journal "Nature Medicine".